Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2B | P18089 | 4/20 | 0.57 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.47 |
| ▸ | DRD2 | P14416 | 4/20 | 0.47 |
| ▸ | DRD3 | P35462 | 4/20 | 0.47 |
| ▸ | HTR2A | P28223 | 3/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.47 |
| ▸ | DRD4 | P21917 | 3/20 | 0.47 |
| ▸ | SLC22A2 | O15244 | 2/20 | 0.47 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.47 |
| ▸ | SLC22A3 | O75751 | 2/20 | 0.47 |
| ▸ | HTR2C | P28335 | 2/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19656193 | 0.88 | CHRM2 (0.54) | ADRA2BADRA2CADRA2ALMNASLC6A4 | |
| SCHEMBL22018905 | 0.88 | HTR2A (0.61) | ADRA2BADRA2CADRA2ALMNASLC6A4 | |
| SCHEMBL20383138 | 0.87 | HTR2A (0.53) | ADRA2BADRA2CADRA2ALMNASLC6A4 | |
| SCHEMBL7708386 | 0.86 | HTR7 (0.51) | ADRA2BADRA2CADRA2ALMNASLC6A4 | |
| SCHEMBL28232463 | 0.85 | ADRA2A (0.48) | ADRA2BADRA2CADRA2ALMNASLC6A4 | |
| SCHEMBL590887 | 0.85 | ALDH1A1 (0.54) | ADRA2BADRA2CLMNASLC6A4DRD2 | |
| SCHEMBL344854 | 0.85 | ALDH1A1 (0.54) | ADRA2BADRA2CLMNASLC6A4DRD2 | |
| SCHEMBL8240109 | 0.85 | HTR7 (0.57) | ADRA2BADRA2CADRA2ADRD2DRD3 | |
| SCHEMBL29643502 | 0.85 | ALDH1A1 (0.54) | ADRA2BADRA2CLMNASLC6A4DRD2 | |
| SCHEMBL9833997 | 0.85 | ADRA2B (0.51) | ADRA2BADRA2CADRA2ALMNASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170047526-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-16 | — | — | US | disclosed |
| US-20080018238-A1 | Use Of Phenothiazine-S-Oxides And Phenothiazine -S,S-Dioxides In The Form Of Matrix Materials For Organic Light-Emitting Diodes | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170047526-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | ADRA2B 3570/4885ADRA2C 3107/4885ADRA2A 3347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.